259 related articles for article (PubMed ID: 3486677)
1. [Inhibition of the binding and activation of the first component of human complement. The effect of synthetic peptides, immunoglobulin fragments and various proteins].
Kozlov LV; Sizoĭ MN; Zinchenko AA; Levkovskiĭ AV
Biokhimiia; 1986 May; 51(5):707-18. PubMed ID: 3486677
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by various peptides of the activation of C1, the first component of complement, and the interaction of C gamma 2 domain of IgG with C1q.
Takada A; Shirahama S; Takada Y
Immunopharmacology; 1985 Apr; 9(2):87-95. PubMed ID: 3888918
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G.
Lukas TJ; Muñoz H; Erickson BW
J Immunol; 1981 Dec; 127(6):2555-60. PubMed ID: 7299136
[TBL] [Abstract][Full Text] [Related]
4. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.
Johnson G; Swart C; Moore SW
Biochem J; 2008 May; 411(3):507-14. PubMed ID: 18215127
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
6. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
7. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
8. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.
Louis JM; Dyda F; Nashed NT; Kimmel AR; Davies DR
Biochemistry; 1998 Feb; 37(8):2105-10. PubMed ID: 9485357
[TBL] [Abstract][Full Text] [Related]
10. Structure-based understanding of ligand affinity using human thrombin as a model system.
Nienaber VL; Mersinger LJ; Kettner CA
Biochemistry; 1996 Jul; 35(30):9690-9. PubMed ID: 8703940
[TBL] [Abstract][Full Text] [Related]
11. Fasciola gigantica cathepsin L proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis.
Jezek J; El Ridi R; Salah M; Wagih A; Aziz HW; Tallima H; El Shafie MH; Khalek TA; Ammou FF; Strongylis C; Moussis V; Tsikaris V
Biopolymers; 2008; 90(3):349-57. PubMed ID: 17549696
[TBL] [Abstract][Full Text] [Related]
12. Effects of soluble aggregates of IgG on the binding, uptake and degradation of the C1q subcomponent of complement by adherent guinea pig peritoneal macrophages.
Veerhuis R; Van Es LA; Daha MR
Eur J Immunol; 1985 Sep; 15(9):881-7. PubMed ID: 3876223
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
14. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
Gardner A; Westfall TC; Macarthur H
J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
[TBL] [Abstract][Full Text] [Related]
15. Interaction between Schistosoma mansoni and the complement system: role of IgG Fc peptides in the activation of the classical pathway by schistosomula.
Ouaissi MA; Auriault C; Santoro F; Capron A
J Immunol; 1981 Oct; 127(4):1556-9. PubMed ID: 7024409
[TBL] [Abstract][Full Text] [Related]
16. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
17. Monkey pepsinogens and pepsins. IV. The amino acid sequence of the activation peptide segment of Japanese monkey pepsinogen.
Kageyama T; Takahashi K
J Biochem; 1980 Jul; 88(1):9-16. PubMed ID: 6773933
[TBL] [Abstract][Full Text] [Related]
18. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of alternative pathway factor D by factor B-related synthetic hexapeptides.
Lesavre P; Gaillard MH; Halbwachs-Mecarelli L
Eur J Immunol; 1982 Mar; 12(3):252-4. PubMed ID: 6920299
[TBL] [Abstract][Full Text] [Related]
20. The binding site for C1q on IgG.
Duncan AR; Winter G
Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
